Before 2026, Medicare Part D — the prescription drug benefit — had no limit on how much a beneficiary could spend on medications in a year. If your drugs were expensive enough, you could spend tens of thousands of dollars annually with no ceiling in sight. For seniors with cancer, multiple sclerosis, rheumatoid arthritis, or other conditions requiring specialty medications, this was not a hypothetical problem.
That changed on January 1, 2026. A provision of the Inflation Reduction Act, signed into law in 2022, established a $2,000 annual out-of-pocket cap on Medicare Part D prescription drug costs — the first hard cap in the program's history. It is one of the most significant changes to Medicare drug coverage in decades.
What the Cap Means in Plain English
Once you have spent $2,000 out-of-pocket on covered Part D drugs in a calendar year, Medicare pays 100% of your remaining covered drug costs for the rest of that year. You pay nothing more.
"Out-of-pocket" includes your deductible, your copays and coinsurance for covered drugs, and what you pay during what used to be called the coverage gap. It does not include your monthly Part D premium.
For seniors who previously hit catastrophic coverage — the old phase where you had paid so much that Medicare covered most costs — the new system is simpler and more protective. There is no longer a donut hole to fall into. There is no longer a catastrophic phase with its own cost-sharing rules. There is just a deductible, a cost-sharing phase, and then a $2,000 cap.
Who Benefits Most
The change is most significant for seniors who take expensive specialty medications. People being treated for cancer, autoimmune conditions, multiple sclerosis, hepatitis C, or other serious illnesses were often the ones spending $5,000, $10,000, or more on Part D drugs each year. For them, the cap could mean tens of thousands of dollars in annual savings.
Seniors who spend relatively little on medications — those who take only generics or whose drugs are inexpensive — will see a less dramatic change in their day-to-day costs. But the cap still matters for them as a form of financial protection against an unexpected diagnosis or a change in medication needs.
According to research from KFF (the Kaiser Family Foundation), millions of Medicare Part D enrollees previously had out-of-pocket drug costs exceeding $2,000 annually. Those beneficiaries are the direct winners of this change.
The Medicare Prescription Payment Plan
Even with a $2,000 cap, some seniors face a cash flow problem: if most of their expensive drugs are filled early in the year, they might hit the cap in February or March — meaning they paid a large lump sum upfront before Medicare took over for the rest of the year.
To address this, the Inflation Reduction Act also created the Medicare Prescription Payment Plan (sometimes called the smoothing option). This lets you spread your expected out-of-pocket drug costs evenly across the 12 months of the year rather than paying large amounts upfront.
If you enroll, Medicare calculates your expected annual drug costs and divides them into equal monthly payments — so instead of paying $800 in January for an expensive medication, you might pay $167 per month for 12 months. You still pay the same total amount (up to $2,000), but the timing is distributed more manageably.
How to enroll: Contact your Part D plan directly. You can opt in at any time during the year, though the sooner you enroll, the more months your payments will be spread across. You can also call 1-800-MEDICARE for guidance.
What Else Changed Under the Inflation Reduction Act
The $2,000 cap is the largest change, but it wasn't the only one. Other drug-related provisions that have already taken effect include:
- Insulin capped at $35 per month — Since 2023, Medicare Part D enrollees pay no more than $35 per month for covered insulin, regardless of the list price. This has saved significant money for the estimated 3.3 million Medicare beneficiaries who use insulin.
- Recommended adult vaccines are free — Since 2023, vaccines recommended by the CDC's Advisory Committee on Immunization Practices — including shingles, pneumonia, and others — are covered at no cost-sharing under Part D.
- Drug price negotiations — Medicare is now negotiating prices directly with drug manufacturers for a set of high-cost drugs. The first round of negotiated prices took effect in 2026. If you take any of the drugs on the negotiated list, you may already be paying less. The list will expand in future years. You can check the current list at medicare.gov.
What You Should Do Now
Even with the cap in place, your Part D plan still matters — and the specific plan you're in determines which drugs are covered, at what tier, and what your deductible and copays are before you hit the cap. Here's what to do to make sure you're in the best position:
- Review your current Part D plan during open enrollment (October 15 – December 7 each year). Use Medicare's Plan Finder tool to compare plans based on the drugs you actually take.
- Track your out-of-pocket spending so you know where you stand relative to the $2,000 cap throughout the year. Your plan's Explanation of Benefits (EOB) should show this.
- Ask about the Medicare Prescription Payment Plan if you have high drug costs early in the year and cash flow is a concern.
- Check the negotiated drug price list to see if any of your medications are on it. If they are, confirm your plan is billing at the negotiated price.
- Contact your State Health Insurance Assistance Program (SHIP) for free, unbiased help reviewing your options. Find your state's SHIP at shiphelp.org.
"The cap doesn't change what your drugs cost — it changes how much of that cost lands on you. For people with serious illnesses, that distinction is enormous."
How Much Should You Budget?
If you take expensive specialty drugs, you can now plan around a clear maximum: $2,000 in out-of-pocket drug costs per year, plus your monthly Part D premium. That predictability is new and valuable — it lets you budget for healthcare the way you budget for other fixed annual expenses.
If your drug costs are typically low, the more important budget question is your Part D premium and whether the plan's formulary (its list of covered drugs) still includes your medications. A plan with a slightly higher premium may cost less overall if it covers your drugs at a lower tier.
Review your plan every fall during open enrollment. Plans can — and do — change their formularies, tiers, and cost structures from year to year. A plan that was right for you in 2025 may not be the best option in 2026.